I’m a Principal Health Data Analyst supporting a range of HDI projects including Real-world Standing Cohorts, analysis of patient pathways and IQVIA projects to test the Simulacrum. Outside work I spend as much time as possible with friends and family, enjoy musicals, eating out and have recently discovered the joys of audio books.
Sophie Jose
Principal Health Data Analyst
Sophie Jose is a Principal Health Data Analyst supporting a range of HDI projects including the Simulacrum, Real-world Standing Cohorts and the Patient Pathway tool.
Education and Awards:
PhD Medical Statistics/Epidemiology
MSc Statistics with Applications in Medicine
BSc Mathematics and its Applications
Publications:
Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England
Sally Moore, Laura Cornic, Christina-Jane Crossman-Barnes, Sophie Jose, Zeyad Khalaf, Kwee Yong, Megan Soutar, ...
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year ...
Cohort study to assess geographical variation in cholangiocarcinoma treatment in England
Jose S, Zalin-Miller A, Knott C, Paley L, Tataru D, Morement H, Toledano MB, Khan SA. Cohort study to assess ...
Real-world evidence for patient outcomes and mutational burden in non-small cell lung (NSCLC) cancer patients in England using EGFR biomarker test data from routine clinical care
Hagenaars S, Ingleby FC, Lambova A, Gaultney J, Parimi M, Huynh J, Benson S, Muwaffak M, Jose S, Frayling L, ...
Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from routine clinical practice in England
Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from ...
P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional treatment in England
P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional ...
Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017
Zalin-Miller A, Jose S, Knott C, Paley L, Tataru D, Morement H, Toledano MB, Khan SA. Regional variation in routes ...
Clinical characteristics, treatments and outcomes in patients diagnosed with hepatocellular carcinoma (HCC) receiving locoregional treatment in England
Blak BT, Sharma R, Zalin-Miller A, Jose S, Mare SL. Clinical characteristics, treatments and outcomes in patients ...
Second primary cancer risks for female and male breast cancer survivors
Isaac Allen; Tameera Rahman; Andrew Bacon; Craig Knott; Sophie Jose; Sally Vernon; Hend Hassan; Catherine ...
Projects:
Simulacrum v2
Cancer Prevalence Statistics for England
Cholangiocarcinoma (AMMF)
National Inherited Cancers Registry
Real-world Standing Cohorts
CAS Explorer
Pathway Viewer
The Simulacrum
Further information:
Linkedin profile